Atlas FDA

ARCHITECT/AEROSET Activated Aspartate Aminotransferase The Activated Asparate Aminotransferase (Activated AST) assay is

FDA device recall Z-1447-2012 · posted 2012-04-23 · Terminated

Recall details

Recalling firm
Abbott Laboratories Inc.
Reason for recall
This letter is to inform you that some samples may generate A-AST results of less than (<) 5 U/L or results within the reference range when actual concentration exceeds the non-Flex linearity of 1985 U/L. In other cases the following errors may be generated. -ARCHITECT cSystems: Error Code 1053 (Unable to calculate result, rate reaction linearity failure) -AEROSET: RL% Error Code Revised P
Action taken
Abbott Laboratories sent a Product Correction letter dated August 5, 2008, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to do the following: Update your assay parameters for A-AST 1. Follow the steps in the appropriate attachment: - Use Attachment A for ARCHITECT cSystems - Use Attachment B for AEROSET. 2. All A-AST results of less than (<) 5 U/L should be evaluated by comparing to other clinically relevant assays Retain a copy of this letter for your laboratory records. For questions regarding this recall call 626-440-0705.
Root cause
Nonconforming Material/Component
Status
Terminated
Product code
CIT
Quantity affected
1,646
Distribution
Worldwide Distribution including Germany
Date initiated
2008-06-30
Date posted
2012-04-23
Date terminated
2012-04-23
Location
South Pasadena, CA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
ACTIVATED ASPARTATE AMINOTRANSFERASE (K071525)Abbott Laboratories2008-03-19